Canadian American Ticlopidine Study "CATS"

Completed

Phase N/A Results

Summary of Purpose

To assess the effect of ticlopidine in reducing the rate of subsequent occurrence of stroke, myocardial infarction, or vascular death in patients who have had a recent thromboembolic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 March 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Syntex Research Inc., and Sanofi, France

Trial Design

Randomized, double-blind, placebo-controlled trial of 1072 patients at 25 centers.

Contacts

Not available